EUVIMEDEUVIMED entdecken
Crossref

Dissemination Phenotypes after First-Line Immunotherapy in Metastatic NSCLC: Implications for Metastasis-Directed Therapy

A.R.R. Kawakibi, N. Choudhury, M. Garassino, C.M. Bestvina, S.J. Chmura, S. Pitroda, A. Juloori

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e698

DOI: 10.1016/j.ijrobp.2026.06.2167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von A.R.R. Kawakibi und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kawakibi, A., Choudhury, N., Garassino, M., Bestvina, C., Chmura, S., Pitroda, S., & Juloori, A. (2026). Dissemination Phenotypes after First-Line Immunotherapy in Metastatic NSCLC: Implications for Metastasis-Directed Therapy. International Journal of Radiation Oncology*Biology*Physics, 126(1), e698. https://doi.org/10.1016/j.ijrobp.2026.06.2167

Vancouver

Kawakibi A, Choudhury N, Garassino M, Bestvina C, Chmura S, Pitroda S, et al. Dissemination Phenotypes after First-Line Immunotherapy in Metastatic NSCLC: Implications for Metastasis-Directed Therapy. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e698. doi:10.1016/j.ijrobp.2026.06.2167

BibTeX
@article{Kawakibi2026,
  author = {Kawakibi, A.R.R. and Choudhury, N. and Garassino, M. and Bestvina, C.M. and Chmura, S.J. and Pitroda, S. and Juloori, A.},
  title = {Dissemination Phenotypes after First-Line Immunotherapy in Metastatic NSCLC: Implications for Metastasis-Directed Therapy},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {e698},
  doi = {10.1016/j.ijrobp.2026.06.2167}
}
Kostenlos starten →